ESMO26: SANOVO data backs 1L Orpathys use in NSCLC subgroup, but AEs temper reaction
Positive Phase III results from the SANOVO and SAFFRON studies with Orpathys raise several sequencing and usage considerations.
Positive Phase III results from the SANOVO and SAFFRON studies with Orpathys raise several sequencing and usage considerations.